Soluble CD26 and CD30 plasma levels in HIV infected patients with and without GB virus type C coinfection

Pakistan Journal of Biological Sciences

Volumn 10, Issue 12, 2007, Pages 2014-2019

  Mostafa, Haji Molla Hoseini ^a   Ali Akbar, Pourfathollah ^a   Zahra, Soheili ^b   Minoo, Mohraz ^c   Sedigheh, Amini ^d   Mahnaz, Aghaiepour ^d   Shahram, Samiee ^d   Mahin, Nikoogoftar ^d   Mina, Moghtadaie ^d  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

Author keywords

Coinfection; GB virus C; HIV; sCD26; sCD30

Indexed keywords

GB VIRUS C; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 34447338592     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2007.2014.2019     Document Type: Article

References (31)

1. Ajdary, S., R. Jafar-Shakib, F. Riazi-rad and M. Mohebbali, 2006. Soluble CD26/CD30 levels in visceral lesihmaniasis: Marker of disease activity. Clin. Exp. Immunol., 145P: 44-47.
2. Ajdary, S., R. Jafar-Shakib, F. Riazi-rad and A. Khamesipour, 2007. Soluble CD26 and CD30 levels in patients with anthroponotic cutaneous leishmaniasis. (In Press).
3. Bengtsson, A., 2001. The role of CD30 in atopic diease. Allergy, 56: 593-603.
4. Birk, M., S. Lindback and C. Lidman, 2002. No influence of GB virus C replication on the prognosis in a cohort of HIV-1 infected patients. AIDS, 16: 2482-2485.
5. Bjorkman, P., L. Flamholc, A. Naucler, V. Molnegren, E. Wallmark and A. Widel, 2004. GB virus C during the natural course of HIV-1 infection: Viremia at diagnosis does not predict mortality. AIDS, 18: 877-886.
6. Boonacker, E.P., E.A. Wierenga, H.H. Smits and C.J.F. Van Noorden, 2002. CD26/DPPIV signal transduction function, but not proteolytic activity, is directly related to its expression level on human Th1 and Th2 cell lines as detected with living cell cytochmistry. J. Histochem. Cytochem., 50: 1169-1177.
7. Boonacker, E.P. and C.J. Van-Noorden, 2003. The multifunctional or moonlighting protein CD26/DPPIV. Eur. J. Cell Biol., 82: 53-73.
8. Che-Chun, S., C. Hsiu-Hui, C. Chia-Che, C. Jui-Chieh and H. Su-ming, 2004. CD30 is involved in inhibition of T cell proliferation by Hodgkin's Reed-Sternberg cells. Cancer Res., 64: 2148-2152.
9. Horie, R. and T. Watanabe, 1998. CD30: Expression and function in health and disease. Semin Immunol., 10: 457-470.
10. Hoshimoto, K., N. Ohta, T. Ohkura and N. Inaba, 2000. Changes in plasma soluble CD26 and CD30 during pregnancy: Markers of Th1/Th2 balance? Gynecol. Obstet. Invest., 50: 260-263.
11. Hosono, O., T. Homma, H. Kobayashi, Y. Munakata, Y. Nojima, A. Iwamoto and C. Morimoto, 1999. Decreased dopeptidyl peptidase IV enzyme activity of plasma soluble CD26 and its inverse correlation with HIV-1 RNA in HIV-1 infected individuals. Clin. Immunol., 91: 283-295.
12. Jacoto, E., C. Callebeaut, J. Blanco, Y. Riviere, B. Krust and A.G. Hovanessian, 1997. CD26 as a positive regulator of HIV envelope- glycoprotein induced apoptosis in CD4+ T cells. Adv. Exp. Med. Biol., 421: 207-216.
13. Keane, N.M., P. Price, S. Lee, S.F. Stone and M.A. French, 2001. An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokine in HIV patients receiving highly active antiretroviral therapy. Clin. Exp. Immunol., 126: 111-116.
14. Kupfer, B., T. Ruf, M. Bertfried, J. Nattermann, U. Spengler, J.K. Rockstroch, H.H. Brackmann, J. Blumel, M. Tacke and R. Kaiser, 2005. Comparison of GB virus C, HIV and HCV infection markers in hemophilia exposed to non-inactivated or inactivated factor concentrates. J. Clin. Virol., Doi: 10:1016/j.jcv.2005.01.008.
15. Nakao, K., Y. Nagake, A. Okamoto, H. Ichikawa, M. Yamamura and H. Makino, 2002. Serum levels of soluble CD26 and CD30 in patients on hemodialysis. Nephron, 91: 215-221.
16. Nunnari, G., L. Nigra, F. Palermo, M. Attanasio, A. Berger, H.W. Doerr, R.J. Pomerantz and B. Caopardo, 2003. Slower progression of HIV-1 infection in persons with GB virus C coinfection correlates with an intact T helper 1 cytokine profile. Ann. Int. Med., 139: 26-30.
17. Ohnuma, K., Y. Munakata, T. Ishii, S. Iwata, S. Kobayashi, O. Hosono, H. Kaeasaki, N.H. Dang and C. Morimoto, 2001. Soluble CD26/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs. J. Immunol., 167: 6745-6755.
18. Ohtsuki, T., H. Tsuda and C. Morimoto, 2000. Good or evil: CD26 and HIV infection. J. Dermatol. Sci., 22: 152-160.
19. Pawlowska, M., W. Halota, E. Grabczewska and A. Olczak, 2003. Concentration of sCD26 in HIV-infected patients. HIV AIDS, Rev., 2: 2-5.
20. Pizzolo, G., F. Vinante, L. Morosato, G. Nadali, M. Chilosi, G. Gandini, A. Sinicco, R. Raiteri, G. Semenzato and H. Stein, 1994. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS, 6: 741-745.
21. Rizzardi, G.P., W. Barcellini, G. Tambussi, F. lillo, M. Malnati, L. Perrin and A. Lazzarin, 1996. Plasma levels of soluble CD30, tumor necrosis factor (TNF)-α and TNF receptor during primary HIV-1 infection: Correlation with HIV-1 RNA and the clinical outcome. AIDS., 10: F45-F50.
22. Rmia, S., J. Mokhbat, A. Sibia, S. Klayme and R. Naman, 2004. HIV epidemiology res. Research groups. Exposure rates to hepatitis C and G virus infections among HIV-infected patients. Int. J. STD AIDS., 15: 463-466.
23. Sabin, C.A., H. Devereux, Z. Kinson, A. Griffioen, D. Brown, G. Dusheiko and C.A. Lee, 1998. Effect of coinfection with hepatitis G virus on HIV disease progression in hemophilic men. J. Acquir Immun. Defic. Syndr. Hum. Retroviral., 19: 546-548.
24. Salgado, F.J., E. Vela, M. Martin, R. Franco, M. Nogueira and O.J. Cordero, 2000. Mechanism of CD26/dopeptidyl peptidase in cytokine-dependent regulation on human activated lymphocytes. Cytokine, 12: 1136-1141.
25. Saraiva, M., P. Smith, P.G. Fallon and A. Alcami, 2002. Inhibition of type I cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus. J. Exp. Med., 196: 829-839.
26. Sathar, M.A., D.F. York, E. Gouws, A. Coutsoudis and H.M. Coovadia, 2004. GB virus type C coinfection in HIV-infected African mothers and their infants, KwaZula Natal, South Africa. Clin. Infect. Dis., 38: 405-409.
27. Simons, J.N., T.P. Leary, G.J. Daeson, T.J. Pilot-matias, A.S. Muerhoff, G.G. Schlauder, S.M. Desai and I.K. Mushahwar, 1995. Isolation of novel virus-like sequences associated with human hepatitis. Nat. Med., 1: 564-569.
28. Tilman, H., H. Heiken, A. Knapik-Botor, S. Heringlake, J. Ockenga, J.C. Wilber, B. Georgen, J. Detmer, M. McMorrow, M. Stoll, R.E. Schmidt and M.P. Manns, 2001. Infection with GB virus and reduced mortality among HIV-infected patients. N Eng. J. Med., 345: 715-724.
29. Van der Bij, A.K., N. Kloosterboer, M. Prins, B. Boeser-Nunnink, R.B. Geskus, J.M. Lange, R.A. Coutinho and H. Schuitemaker, 2005. GB Virus C Coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J. Infect. Dis., 191: 678-685.
30. Williams, C., D. Klinzman, T.E. Yamashita, J. Xiang, P.M. Polgreen, C. Rinaldo, C. Liu, J. Phair, J.B. Margolick, D. Zedunek, G. Hess and J.T. Stepleton, 2004. Persistent GB virus infection and survival in HIV infected men. N Eng. J. Med., 350: 981-990.
31. Xiang, J., S. Wunschmann, D.J. Diekema, D. Kilinzman, K.D. Patrick, S.L. Gorge and J.T. Stapleton, 2001. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Eng. J. Med., 345: 707-714.